Healthbeat - Your Source for Daily Health Trends and Medical News

Younger generations less likely to have dementia, study suggests

Researchers say people born more recently, particularly women, have lower risk at same age as their grandparentsPeople born more recently are less likely to have dementia at any given age than earlier

Ingredient up to 13,000 times sweeter than sugar lurks in vapes popular with teens, study shows

An artificial sweetener called neotame was found in disposable vapes popular with teens.

At least 20 Planned Parenthood clinics shutter amid political turbulence

The reproductive health giant is navigating a loss of federal funding and fresh threats from multiple directionsAt least 20 Planned Parenthood clinics across seven states have shuttered since the star

Police launch corporate manslaughter inquiry into Nottingham hospital trust

Inquiry into Nottingham university hospitals NHS trust follows deaths and serious injuries related to maternity careAn NHS trust is being investigated on suspicion of corporate manslaughter after the

VA Restricts Research Publishing; Makary Bashes CDC Committee; Musk's Drug Use

(MedPage Today) -- Note that some links may require registration or subscription.

Another Covid vaccine approval with restrictions attached

And more Monday morning health news.

UK shortage of critical drug forcing pancreatic cancer patients to skip meals

One pharmacist described scarcity of life-saving Creon as ‘worst stock shortage’ they have dealt withPeople with pancreatic cancer are eating only one meal a day because of an acute shortage of a

STAT+: Pharmalittle: We’re reading about Sanofi buying Blueprint, a Bristol deal with BioNTech and more

Let's take a walk around the Pharmalot campus this Monday.

STAT+: Enhertu, used as first option, stalled tumors for more than a year in women with breast cancer, study finds

The cancer drug Enhertu stalled the growth of tumors by well over a year in a group of women with a type of metastatic but previously untreated breast cancer, a…

ADC-Pertuzumab Promising as New Standard in HER2-Positive Metastatic Breast Cancer

(MedPage Today) -- CHICAGO -- First-line trastuzumab deruxtecan (T-DXd) combined with pertuzumab (Perjeta) improved progression-free survival (PFS) in HER2-positive locally advanced or metastatic b

All News